BeStock  
Stocks › Medical Devices › ALMR

Alamar Biosciences ALMR

US equityMarket cap rank #2730Medical Devices
$26.48 −$2.20 (-7.67%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.50 +0.08%
Open$28.25
Prev close$28.68
Day range$26.24 – $28.25
Volume712.6K
Market cap$1.84B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$33.55M+68.5% YoY
Operating profit-$15.14M-92.0% YoY
Net profit-$13.34M-66.8% YoY
Diluted EPS-$0.19-58.0% YoY
Free cash flow-$15.37M+0.6% YoY
Operating cash flow-$14.73M

Revenue, last 7 quarters

$13.1MMar '25$16.2MJun '25$19.9MSep '25$25.0MDec '25$26.0MMar '26$29.4MJun '26$33.5MSep '26

Net profit, last 7 quarters

$-7.7MMar '25$-7.0MJun '25$-8.0MSep '25$-7.1MDec '25$-21.3MMar '26$-13.2MJun '26$-13.3MSep '26

Diluted EPS by quarter

-0.12Mar '25-0.11Jun '25-0.12Sep '25-0.11Dec '25-0.32Mar '26-0.22Jun '26-0.19Sep '26

Free cash flow by quarter

$-14.1MMar '25$-13.0MJun '25$-15.5MSep '25$-17.5MDec '25$-21.1MMar '26$-15.1MJun '26$-15.4MSep '26

Profitability & balance sheet

Gross margin59.3%
Operating margin-42.1%
Net margin-48.2%
Return on equity-18.1%
Return on assets-14.5%
Return on invested capital-16.6%
Current ratio9.49
Liabilities / assets19.7%
Cash & investments$226.59M
Total debt$39.87M
Net cash (debt)$186.72M

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Consumables$17.83M 53.2%
  • Instruments$8.47M 25.2%
  • Services$7.25M 21.6%

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $378.03M $390.98M $186.45M $139.99M $139.99M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Retained Earnings -$216.64M -$203.30M -$190.10M -$168.78M -$168.78M
Gains/Losses Not Affecting Retained Earnings -$173,000.00 -$139,000.00 -$80,000.00 -$72,000.00 -$72,000.00
-Gross PPE $51.48M $49.16M $36.14M $44.97M $44.97M
Capital Stock $7,000.00 $7,000.00 $1,000.00 $1,000.00 $1,000.00
Stockholders' Equity $303.70M $312.86M -$178.07M -$158.95M -$158.95M
Total Equity $303.70M $312.86M -$178.07M -$158.95M -$158.95M
Other Non-Current Liabilities $974,000.00 $1.03M $1.20M $599,000.00 $599,000.00
Convertible preferred securities $0.00 $0.00 $235.00M $235.00M $235.00M
Derivative Product Liabilities $0.00 $0.00 $331,000.00 $247,000.00 $247,000.00
-Long Term Capital Lease Obligation $39.87M $39.18M $28.98M $29.56M $29.56M
Long Term Debt and Capital Lease Obligation $39.87M $49.13M $103.95M $39.37M $39.37M
Total Non-Current Liabilities $40.84M $50.16M $340.47M $275.22M $275.22M
Goodwill and Other Intangible Assets $1.44M $1.61M $1.84M $1.99M $1.99M
Current Deferred Liabilities $1.79M $2.19M $4.20M $1.20M $1.20M
Net PPE $51.48M $49.16M $36.14M $36.63M $36.63M
-Other Intangible Assets $1.44M $1.61M $1.84M $1.99M $1.99M
-Current Capital Lease Obligation $2.48M $2.28M $1.60M $2.10M $2.10M
Short-Term Debt and Capital Lease Obligation $2.48M $2.28M $1.60M $2.10M $2.10M
Current Accrued Expenses $5.34M $4.55M $9.52M $7.70M $7.70M
-Accounts Payable $16.55M $13.79M $5.64M $5.87M $5.87M
Additional Paid-In Capital $520.51M $516.29M $12.11M $9.89M $9.89M
Payables $16.55M $13.79M $5.64M $5.87M $5.87M
Total Current Liabilities $33.48M $27.96M $24.05M $23.73M $23.73M
Total Liabilities $74.32M $78.12M $364.52M $298.95M $298.95M
Other Non-Current Assets $7.42M $8.83M $7.00M $6.67M $6.67M
Total Non-Current Assets $60.34M $59.59M $44.98M $45.29M $45.29M
Other Current Assets $15.36M $15.58M $17.43M $13.47M $13.47M
Total Current Assets $317.69M $331.38M $141.47M $94.71M $94.71M
Cash and Cash Equivalents & Short-Term Investments $226.59M $250.05M $64.59M $30.00M $30.00M
-Cash and Cash Equivalents $121.53M $132.97M $64.59M $30.00M $30.00M
-Common Stock $7,000.00 $7,000.00 $1,000.00 $1,000.00 $1,000.00
-Short Term Investments $105.05M $117.08M – $0.00 $0.00
Receivables $21.61M $20.34M $19.52M $12.75M $12.75M
-Accounts Receivable $21.61M $20.34M $19.52M $12.75M $12.75M
Inventory $54.13M $45.41M $39.93M $38.48M $38.48M
-Long Term Debt – $9.95M $74.97M $9.81M $9.81M
-Accumulated Depreciation – – – -$8.34M -$8.34M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 Q4 2025 ANNUAL
Tax $94,000.00 -$93,000.00 $464,000.00 $225,000.00 $665,000.00
Net Profit -$13.34M -$13.20M -$21.33M -$7.14M -$29.82M
Profit from Continuing Operations -$13.34M -$13.20M -$21.33M -$7.14M -$29.82M
Net Income to Parent Company -$13.34M -$13.20M -$21.33M -$7.14M -$29.82M
Net Income to Common Stockholders -$13.34M -$13.20M -$21.33M -$7.14M -$29.82M
Basic EPS -$0.19 -$0.22 -$0.32 -$0.11 -$0.45
Diluted EPS -$0.19 -$0.22 -$0.32 -$0.11 -$0.45
Pretax Profit -$13.25M -$13.29M -$20.86M -$6.91M -$29.15M
Other Non-Operating Income (Expenses) -$125,000.00 -$1.41M -$8.83M -$46,000.00 $421,000.00
Other Income (Expense) -$125,000.00 -$1.41M -$8.83M -$46,000.00 $421,000.00
Gross Profit $20.64M $17.72M $14.46M $14.84M $41.71M
Cost of Revenue $12.90M $11.71M $11.58M $10.21M $32.51M
Total Operating Revenue $33.55M $29.43M $26.04M $25.05M $74.21M
Total Revenue as Reported $33.55M $29.43M $26.04M $25.05M $74.21M
Selling and Admin Expenses $19.62M $17.43M $13.79M $11.75M $35.57M
Research & Development $16.17M $13.82M $13.02M $10.07M $37.47M
Operating Profit -$15.14M -$13.53M -$12.35M -$6.98M -$31.33M
Net Non-Operating Interest Income (Expense) $2.02M $1.65M $316,000.00 $112,000.00 $1.76M
Non-Operating Interest Income $2.17M $1.88M $539,000.00 $334,000.00 $2.16M
Non-Operating Interest Expense $153,000.00 $224,000.00 $223,000.00 $222,000.00 $401,000.00
Operating Expense $35.78M $31.25M $26.80M $21.82M $73.04M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Financing Cash Flow -$9.85M $201.84M $55.76M $10.84M $28,000.00
-Change in Other Current Assets $364,000.00 -$484,000.00 -$327,000.00 -$746,000.00 -$979,000.00
-Change in Payables and Accrued Expense $4.08M $3.11M $105,000.00 $5.81M $908,000.00
-Change in Prepaid Assets $214,000.00 -$900,000.00 -$1.96M -$6.44M -$2.86M
-Change in Inventory -$10.21M -$5.73M -$1.27M -$23.78M -$4.93M
-Change in Receivables -$1.32M -$967,000.00 -$6.85M -$5.50M -$1.76M
Change in Working Capital -$7.05M -$4.78M -$11.39M -$32.57M -$10.08M
Other Non-Cash Items $702,000.00 $754,000.00 $889,000.00 $2.13M $551,000.00
Depreciation & Depletion & Amortization $1.42M $1.13M $1.17M $3.86M $1.07M
Gain/Loss from Continuing Operations $58,000.00 $113,000.00 $249,000.00 $42,000.00 $178,000.00
Net Income from Continuing Operations -$13.34M -$13.20M -$21.33M -$29.82M -$7.14M
Net cash flow from continuing operations -$14.73M -$11.32M -$20.35M -$53.61M -$14.52M
-Change in Other Current Liabilities -$183,000.00 $184,000.00 -$1.09M -$1.92M -$457,000.00
Net cash flow from investing $11.74M -$120.80M -$778,000.00 $46.18M -$2.98M
Net Cash Flow from Continuing Investing Activities $11.74M -$120.80M -$778,000.00 $46.18M -$2.98M
Free Cash Flow -$15.37M -$15.07M -$21.13M -$59.99M -$17.48M
Effect of Exchange Rate Changes $57,000.00 $7,000.00 -$52,000.00 -$172,000.00 -$172,000.00
Beginning Cash Balance $139.22M $69.49M $34.91M $31.68M $52.55M
Net Change in Cash -$12.84M $69.72M $34.64M $3.40M -$17.47M
Net Other Financing Charges -$119,000.00 -$3.93M -$2.54M -$657,000.00 -$596,000.00
Net Common Stock Issuance $270,000.00 $205.77M $1.80M $1.49M $624,000.00
Net Issuance Payments Of Debt -$10.00M $0.00 $56.50M $10.00M $0.00
Net Cash Flow from Continuing Financing Activities -$9.85M $201.84M $55.76M $10.84M $28,000.00
Net Investment Purchase and Sale $12.38M -$117.05M $0.00 $52.56M -$23,000.00
Net PPE Purchase and Sale -$463,000.00 -$3.64M -$600,000.00 -$5.37M -$2.85M
Capital Expenditure -$179,000.00 -$109,000.00 -$178,000.00 -$1.01M -$111,000.00
Operating Cash Flow -$14.73M -$11.32M -$20.35M -$53.61M -$14.52M
Ending Cash Balance $126.44M $139.22M $69.49M $34.91M $34.91M
Net Preferred Stock Issuance – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on ALMR.

Sign in to join the discussion.

Scroll to Top